Tenaya Therapeutics, Inc.
TNYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $121 | $239 | $90 | $782 |
| - Cash | $4 | $46 | $95 | $38 |
| + Debt | $14 | $12 | $15 | $14 |
| Enterprise Value | $131 | $206 | $10 | $758 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$8 | -$9 | -$9 | -$4 |
| % Margin | – | – | – | – |
| EBITDA | -$103 | -$115 | -$115 | -$69 |
| % Margin | – | – | – | – |
| Net Income | -$111 | -$124 | -$124 | -$73 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.31 | -1.68 | -2.76 | -1.69 |
| % Growth | 22% | 39.1% | -63.3% | – |
| Operating Cash Flow | -$91 | -$102 | -$104 | -$61 |
| Capital Expenditures | -$1 | -$1 | -$21 | -$25 |
| Free Cash Flow | -$92 | -$103 | -$125 | -$86 |